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Purpose: Seasonality of skin cancer is well known, and it is influenced by a number 
of variables, such as exposure and personal characteristics, but also health service 
factors. We investigated the variations in the diagnosis melanoma skin cancer (MSC) 
and non-melanoma skin cancer (NMSC) during the year.
Methods: We analyzed incident cases recorded in the Umbria Regional Cancer reg-
istry from 1994 to 2010 (1745 cases of MSC, 50% females, and 15,992 NMSC, 41% 
females). The Walter–Elwood test was used to assess seasonal effects. Relative risks 
were analyzed using negative binomial regression and splines.
results: Seasonality of MSC and NMSC was similar. Incidence peaks were observed 
in weeks 8, 24, and 43 (February, July, and October) and troughs in weeks 16, 32, 52, 
and 1 (August and December). Both NMSC and MSC cancers showed most elevated 
risks in autumn. A seasonal effect was present for trunk (p < 0.001) and absent for face 
cancers (p = 0.3).
conclusion: The observed pattern of diagnoses presumably depends on health service 
factors (e.g., organization of melanoma days, reduced access to care in August and 
during Christmas holidays) and personal factors (e.g., unclothing in the summer and 
delays in seeking care). High incidence rates in autumn could also in part depend on a 
late cancer progression effect of UV exposure. More efforts should be placed in order to 
guarantee uniform access to care through the year.
Keywords: seasonal variation, skin cancers, melanoma, UV, cancer registry, access to care
inTrODUcTiOn
The seasonality of skin cancer occurrence has been confirmed in several studies (1–3). Seasonality 
has been explained with exposure, personal and health service factors, or a combination of the 
above. Several studies have suggested that chronic, low dose of ultraviolet radiation (UVR) may 
minimize the damage incurred from subsequent high-dose exposures; in fact, it has been dem-
onstrated that suberythemal UVR is associated with stimulation of antioxidant enzymes (4–6), 
epidermal thickening, and enhanced DNA repair (1, 7, 8). Others have shown that repeated daily 
exposure of low-dose radiation can be demonstrated by the accumulation of epidermal DNA dam-
age (9). The balance between the protection gained and damage incurred most likely depends 
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on skin phototype and inherent DNA repair ability. Seasonality 
has been also referred to more intense exposure to UVR in the 
summer (3, 10, 11).
Some authors emphasized the influence of campaigns for 
early detection and more frequent detection of skin lesions due 
to unclothing in late spring and early summer (1–3, 12, 13).
In the Umbria, region of central Italy, non-melanoma skin 
cancer (MSC) is the most frequent cancer site. Incidence of 
melanoma is rather low, but an increasing trend is reported in 
both sexes. The standardized incidence rates (per 100,000 inhab-
itants) have increased, from 1994–1996 to 2008–2010, for MSC 
from 6.5 to 11.8 in males and from 6.4 to 11.5 in females, and 
from 65.5 to 103.8 in males and from 34.7 to 54.9 in females for 
non-melanoma skin cancer (NMSC) (14). Similar trends were 
reported for many western countries in the same period (15, 16). 
Explanations proposed for the observed trend include increased 
exposure to risk factors (e.g., sun exposure) and increasing skin 
examination for the early diagnosis of melanoma (17, 18). A 
number of statistical tests for the analysis of seasonal data, such as 
sinusoidal logistic regression, have been presented in the literature 
(19). This paper proposed an analysis that remove any constraint 
on seasonal pattern and also used weekly diagnosis data. Seasonal 
effects can contribute to define the role of risk factor exposures 
and diagnostic intensity in determining actual incidence patterns 
and trends. Therefore, we analyzed incident cases recorded in the 
Regional Cancer registry from 1994 to 2010. The primary goal of 
this paper is to investigate the influence of date of diagnosis on 
MSC and NMSC incidence.
cases anD MeThODs
The Umbrian Cancer Registry (RTUP) started its activity in 1994 
and covers a population of about 900,000 units, resident in the 
Umbria region, Italy. The population can be considered homo-
geneous for genetic background and social habits. This ensures 
that less confounding factors are present. Cases were collected 
in accordance with standard methods for cancer registries (20). 
Cancer type and site were coded using the ICD10 classification 
system (21). Cancer registry data were acquired and managed 
according to Italian laws and international quality rules for cancer 
registries. The in-house developed software guarantees also the 
anonymization of data management within the registry. The 
information system of the Umbria Cancer Registry (S.G.RTUP) 
was used for data management (22). Even if the microscopic 
verifications performed by regional dermatopathologists are 
regularly acquired, an additional investigation was performed for 
cases among all regional dermatologists to ensure completeness.
The incidence rate was calculated per 100,000 residents per 
year. The morphological verification was considered the date 
of diagnosis. The monthly incidence was calculated taking into 
account the exact numbers of days. Due to the relatively small 
number of cases, the incidence of melanoma was examined in 
total. Besides considering the overall distribution of cases by 
month of diagnosis, a comparison was made between two NMSC 
subsites: face (C44.0–C44.3 ICD10; 8700 cases) vs. trunk (C44.5 
ICD10; 1800 cases). This is in order to explore the influence of 
clothing.
The Regional Central Reservations database, available from 
2005, was used to extract skin-related specialist outpatient care 
codes. The selected procedures were removals of radical injury 
of the skin, removals or demolitions of local skin and subcuta-
neous tissue injury, and histopathological exams of skin or soft 
tissue from excisional biopsy. The weekly crude activity rate was 
evaluated as ratio between the number of access to the special-
ist outpatient and the population of the week. The statistical 
evaluation of seasonality on monthly data, adjusted for varying 
population at risk, was carried out by the Walter and Elwood 
test (23). The seasonality test and the goodness of fit test were 
produced. The chi-square test was used to compare distributions 
by gender.
To investigate the association between incidence and diagno-
sis month, we used negative binomial regression. This is used for 
count data when the counts are overdispersed, making a Poisson 
model inappropriate. Indeed, the heterogeneity parameter was 
significant in both the MSC (p  <  0.001) and NMSC models 
(p < 0.001). The appropriate population at risk was included in 
the models (24). Nested models were compared using the likeli-
hood ratio test.
A multivariate regression spline model was used to describe the 
correlation between incidence and month of diagnosis. Weekly 
data were used to obtain a better approximation of the spline 
function to the observed risks. Flexible models were adjusted by 
gender and sites (25). All tests were two sided, and results with 
p < 0.05 were considered significant. Analyses were carried out 
using Stata statistical software (26).
resUlTs
The site distribution and the number of examined cases are 
reported in Table 1. Importantly, 99.1% of MSC diagnoses and 
99.4% of NMSC were of known morphology (i.e., microscopic 
verification was available). The subsite was specified in 89.9% 
of MSC and 85.8% of NMSC. Only two cases were known from 
death certificates only (DCO), and only six melanomas cases 
came from hospital discharge forms (SDO).
In the period considered, 1745 cases of MSC (50% females) 
and 15,992 NMSC (41% females) were registered. The most 
frequent subsite for MSC was trunk (ICD 10 C43.5; 355 cases) 
and lower limb (ICD 10 C43.7; 342 cases) in males and females, 
respectively. Face (ICD 10 C44.3) was the most frequent NMSC 
subsite in both sexes (3313 cases in men and 2811 in women). All 
seasonality trends examined came out to be statically significant 
(Table 2).
The monthly distribution by gender for NMSC was not statis-
tically different (chi-square test, p = 0.8). Comparing face NMSC 
with those of trunk, incidence differs for month of diagnosis 
(chi-square test, p <  0.001). Figure  1 pictures these seasonal 
trends. The monthly distribution of incidence of diagnosis of 
MSC and NMSC was similar and presented two peaks (the first 
one from February to July and the second peak from September 
to November). The lowest rates were recorded in August and in 
December–January.
Figure 2 shows the seasonality of face and trunk skin carci-
nomas by month of diagnosis. For both sites, the minimum was 
TaBle 2 | results of Walter–elwood test for seasonality.
cancer type/site gender P goodness of fit (p)
C43 MSC M + F 0.0014 0.008
C44 NMSC F <0.001 <0.001
C44 NMSC M <0.001 <0.001
C44.0-0.3 face M + F <0.001 <0.001
C44.5 trunk M + F 0.0013 <0.001
TaBle 1 | skin cancer subsites.
Msc c43 nMsc c44
Males Females Total Males Females Total
All subsites 870 875 1745 9475 6517 15,992
0.0 Skin of lip 0 2 2 290 195 485
0.1 Eyelid 2 6 8 434 390 824
0.2 External ear 12 12 24 896 172 1068
0.3 Other and 
unsp. Parts of face
61 87 148 3455 2868 6323
0.4 Scalp and neck 45 25 70 870 432 1302
0.5 Trunk 354 183 537 1099 701 1800
0.6 Upper limb 141 136 277 427 360 887
0.7 Lower limb 157 341 498 236 365 601
0.8 Overlapping 4 1 5 301 135 436
0.9 Skin, 
unspecified
94 82 176 1367 899 2266
FigUre 1 | incidence of skin cancers by month of diagnosis (M + F).
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Restricted cubic splines were used in the negative binomial 
regression model to explore a continuous risk function for date 
of diagnosis (Figure 3). A single spline was used for MSC and 
NMSC cancers, assuming a common underling risk function. 
NMSC cases have more influence on the estimated functions than 
MSC due to the number of cases. Observed MSC and NMSC rates 
were plotted together with splines to provide a visual comparison 
of the continuous risk function to observed data. Notably, the 
result for date of diagnosis showed three separate high incidence 
peaks.
Figure 4 showed the weekly crude activity rate for skin-related 
procedures. The minimum of the activity rate were in August and 
Christmas period as for the overall skin cancer risk.
DiscUssiOn
We observed that the registered incidence of skin cancers has 
a strong seasonal pattern. The incidence pattern supports the 
hypothesis that the seasonality of diagnosis is prevalently due 
to both personal factors (e.g., unclothing in the summer) and to 
access to care in different periods of the year.
Early diagnosis initiatives and summer unclothing can explain 
the incidence peak observed both for melanomas and carcinomas 
in the May–June period. In particular, in the Umbria region, a 
“skin cancer day” is carried out once a year on the first of May. 
Other initiatives including the “European Melanoma Day” take 
place also in late May or in June. As expected, these influences are 
less relevant for NMSC.
The difference in the seasonality of diagnoses observed for 
face and trunk NMSC probably reflects different exposure to 
inspection of body sites over the year. Moreover, the inci-
dence of trunk NMSC is higher in the early summer than in 
autumn. The incidence pattern of trunk NMSC is similar to 
that of MSC and confirms the outcome reported by others 
for MSC (3–7).
The incidence peak in autumn could be explained by the delayed 
referral to medical examination of the skin lesions self-detected 
during August. UV exposure can also increase the pigmentation 
confirmed in August, but the number of trunk carcinoma cases 
was higher in spring while those of face were higher in autumn.
We fitted separate negative binomial regression models by 
cancer type for month of diagnosis (Table 3). This allows inspec-
tion and comparison of relative risks without constraint on 
seasonal pattern.
We tested for a difference of incidence pattern by date of 
diagnosis. The negative binomial regression models including 
interaction terms between cancer type and month were compared 
to the nested models including main effects only. The results of 
the likelihood ratio tests were non-significant (p = 0.98).
TaBle 3 | negative binomial regression models for nMsc and Msc cancers by month of diagnosis.
Month nMsc (c44) Msc (c43)
irr 95% ci p irr 95% ci p
January 1.00 0.92 1.09 0.99 1.22 0.95 1.58 0.12
February 1.12 1.03 1.22 0.007 1.22 0.95 1.58 0.12
March 1.18 1.09 1.28 <0.001 1.31 1.02 1.68 0.04
April 1.01 0.93 1.10 0.81 1.21 0.94 1.57 0.14
May 1.25 1.15 1.36 <0.001 1.38 1.08 1.77 0.01
June 1.21 1.12 1.31 <0.001 1.50 1.18 1.92 0.001
July 1.29 1.19 1.40 <0.001 1.76 1.39 2.23 <0.001
August 0.86 0.79 0.94 0.001 1.11 0.86 1.44 0.43
September 1.34 1.23 1.45 <0.001 1.55 1.21 1.97 <0.001
October 1.58 1.46 1.70 <0.001 1.55 1.21 1.97 <0.001
November 1.43 1.32 1.54 <0.001 1.40 1.09 1.79 0.008
Decembera Ref. Ref.
Gender
Males Ref. Ref.
Females 0.66 0.64 0.68 <0.001 0.94 0.86 1.03 0.21
aReference category is the month with the lowest incidence.
FigUre 2 | incidence of nMsc by month of diagnosis for face and trunk subsites (M + F).
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in melanocytic nevi that facilitates the detection of new or chang-
ing skin lesions (3, 27, 28). UV exposure causes both DNA dam-
age and immunosuppression (29, 30). Chronic UV exposure is 
associated with skin cancer risk (31). Immunosuppression is also 
associated with skin cancer risk, particularly with NMSC (32). 
Indeed intense UV exposure during summer could even act as a 
late promoter with a short-term action (33). As the excess risk in 
autumn is much more evident for NMSC and it is present both 
for trunk and face subsites, the “late promoter hypothesis” clearly 
fits with the data for this cancer type, highlighting the need for 
further studies on this topic.
The strong decrease of diagnoses in August is likely due to 
the holiday period, relevant for both patients (delayed care 
seeking) and physicians (reduced access). Since in Italy, the paid 
leave regime offers 4 weeks’ vacation every year (34) and most 
people tend to take it in August, non-critical medical needs are 
often postponed (35). The same explanation (i.e., reduced access 
 during Christmas holidays) applies to the low incidence rates that 
we observed in December and January. The effects of reduced 
access to care followed by an increase of diagnoses are evident 
from the weekly incidence rates and spline function (Figure 3). 
Previous studies, instead, analyzed only monthly data, therefore 
providing less informative results. Indeed average monthly risk 
(e.g., in January) can conceal a low incidence period followed 
by an incidence peak during the same month. Ideally, access to 
care should be uniformly warranted through all the year in order 
to avoid delayed diagnosis of skin cancer. In fact although the 
observed delays are unlikely to influence prognosis in most cases 
(36), we cannot exclude that selected patients would benefit from 
earlier diagnosis.
FigUre 4 | Weekly activity rates from 2005 to 2010 and overall skin cancer risk.
FigUre 3 | regression spline models for overall skin cancer risk adjusted by gender, site and population at risk by week of incidence.
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In general, the pattern of MSC incidence observed in this 
study is similar to that reported in another multicentric study 
performed by the Italian cancer registries (3).
Skin cancers pose a problem of completeness to cancer 
registries, as surgical treatment can be performed without 
hospitalization and histological verification can be carried out 
by a dermatopathologist, thereby not resulting in any cancer 
registry data sources (37). As a result, many cancer registries do 
not collect NMSC data at all because additional data source is 
needed to ensure completeness of registration (38, 39). Indeed, 
we performed an additional active search for cases among all 
regional dermatologists and regularly acquire archives from 
dermatopathologists to avoid incompleteness of registration. 
Therefore, we believe that population-based studies on NMSC, 
like ours, despite infrequent, do provide important information.
The present study has limitations. It is a retrospective study 
based on cancer registry data. Thus, the interpretation proposed 
for the observed seasonal pattern are speculative and should be 
confirmed in further analytic studies, even though we strength-
ened our observations with specific analyses (i.e., the weekly 
analyses showing strict correspondence between holidays period 
and incidence, comparison between cloth-covered sites and face 
skin cancer incidence, ecologic comparison with skin resection 
procedures).
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In this paper, we applied the flexible parametric model as in 
our previous work (40). In principle, this model has the advantage 
to avoid constraint on seasonal pattern. However, a comparison 
of results from different methods in use to investigate seasonality 
would be interesting.
In conclusion, a seasonal effect was present in the diagnosis of 
MSC and NMSC; it is likely that pattern of incidence by month 
of diagnosis largely depends on health service factors (e.g., 
organization of melanoma days, reduced access to care in August 
and Christmas holidays) and personal factors (e.g., unclothing in 
summer and delay in seeking care). UV-associated immunosup-
pression and DNA damage due to summer UV exposure could 
be a late event in skin carcinogenesis, and it could contribute to 
explain the highest NMSC incidence peak observed in autumn.
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